Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation
- PMID: 27168312
- PMCID: PMC5106332
- DOI: 10.1038/ja.2016.48
Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation
Abstract
The class A β-lactamase GES-22 has been identified in Acinetobacter baumannii isolates in Turkey, and subsequently shown to differ from GES-11 by a single substitution (M169L). Because M169 is part of the omega loop, a structure that is known to have major effects on substrate selectivity in class A β-lactamases, we expressed, purified and kinetically characterized this novel variant. Our results show that compared with GES-116 × His, GES-226 × His displays more efficient hydrolysis of penicillins, and aztreonam, but a loss of efficiency against ceftazidime. In addition, the M169L substitution confers on GES-22 more efficient hydrolysis of the mechanistic inhibitors clavulanic acid and sulbactam. These effects are highly similar to other mutations at the homologous position in other class A β-lactamases, suggesting that this methionine has a key structural role in aligning active site residues and in substrate selectivity across the class.
Figures




Similar articles
-
Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 β-lactamases.Antimicrob Agents Chemother. 2012 Nov;56(11):5618-25. doi: 10.1128/AAC.01272-12. Epub 2012 Aug 20. Antimicrob Agents Chemother. 2012. PMID: 22908160 Free PMC article.
-
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.Antimicrob Agents Chemother. 2009 Aug;53(8):3579-81. doi: 10.1128/AAC.00072-09. Epub 2009 May 18. Antimicrob Agents Chemother. 2009. PMID: 19451292 Free PMC article.
-
Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii.Antimicrob Agents Chemother. 2011 Jan;55(1):349-54. doi: 10.1128/AAC.00773-10. Epub 2010 Oct 18. Antimicrob Agents Chemother. 2011. PMID: 20956589 Free PMC article.
-
Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N132G in the Conserved SDN Motif.Antimicrob Agents Chemother. 2017 Feb 23;61(3):e02510-16. doi: 10.1128/AAC.02510-16. Print 2017 Mar. Antimicrob Agents Chemother. 2017. PMID: 28069651 Free PMC article.
-
Acinetobacter baumannii: biology and drug resistance - role of carbapenemases.Folia Histochem Cytobiol. 2016;54(2):61-74. doi: 10.5603/FHC.a2016.0009. Epub 2016 Jun 8. Folia Histochem Cytobiol. 2016. PMID: 27270503 Review.
Cited by
-
Acinetobacter baumannii: an evolving and cunning opponent.Front Microbiol. 2024 Jan 22;15:1332108. doi: 10.3389/fmicb.2024.1332108. eCollection 2024. Front Microbiol. 2024. PMID: 38318341 Free PMC article. Review.
-
Phylogenetic predictions of carbapenemase activity from the Guiana extended-spectrum (GES) family of β-lactamases.JAC Antimicrob Resist. 2024 Jan 11;6(1):dlad150. doi: 10.1093/jacamr/dlad150. eCollection 2024 Feb. JAC Antimicrob Resist. 2024. PMID: 38213313 Free PMC article.
References
-
- Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159–166. - PubMed
-
- Cicek AC, et al. OXA- and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect. 2014;20:410–405. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical